Peter J Havel Selected Research

Triglycerides (Triacylglycerol)

1/2021	Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study.
6/2019	Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans.
1/2019	Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference.
1/2018	Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage.
2/2017	Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.
5/2014	A stable isotope biomarker of marine food intake captures associations between n-3 fatty acid intake and chronic disease risk in a Yup'ik study population, and detects new associations with blood pressure and adiponectin.
12/2013	Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes.
8/2013	On-chip phenotypic analysis of inflammatory monocytes in atherogenesis and myocardial infarction.
8/2011	Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.
1/2011	Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Havel Research Topics

Disease

57	Insulin Resistance 01/2024 - 02/2002
38	Type 2 Diabetes Mellitus (MODY) 03/2024 - 08/2003
33	Obesity 01/2023 - 02/2002
29	Body Weight (Weight, Body) 03/2024 - 11/2002
16	Weight Loss (Weight Reduction) 01/2021 - 04/2003
15	Weight Gain 01/2023 - 02/2002
14	Overweight 02/2021 - 01/2004
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2020 - 01/2007
12	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 01/2004
10	Inflammation (Inflammations) 05/2022 - 06/2008
10	Dyslipidemias (Dyslipidemia) 03/2020 - 02/2008
9	Hyperglycemia 11/2021 - 02/2006
6	Hypertriglyceridemia 01/2020 - 02/2008
5	Diabetes Mellitus 05/2022 - 11/2006
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020 - 01/2002
5	Hyperinsulinism (Hyperinsulinemia) 02/2012 - 09/2002
4	Metabolic Diseases (Metabolic Disease) 10/2019 - 10/2012
4	Hyperlipidemias (Hyperlipidemia) 07/2011 - 02/2002
3	Hypoglycemia (Reactive Hypoglycemia) 12/2020 - 01/2002
3	Atherosclerosis 12/2017 - 06/2008
3	Glucose Intolerance 05/2010 - 06/2002
2	Non-alcoholic Fatty Liver Disease 02/2022 - 12/2010
2	Prediabetic State (Prediabetes) 01/2022 - 02/2012
2	Hypercholesterolemia 01/2018 - 09/2016
2	Fibrosis (Cirrhosis) 12/2017 - 12/2010
2	Fatty Liver 12/2017 - 07/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2017 - 06/2007
2	Proteinuria 01/2017 - 01/2017
2	Gastroesophageal Reflux (GERD) 01/2016 - 12/2015
2	Barrett Esophagus (Barrett's Esophagus) 01/2016 - 12/2015
2	Nausea 06/2015 - 03/2015
2	Abdominal Obesity 01/2015 - 08/2011
2	Myocardial Infarction 08/2013 - 12/2006
2	Coronary Disease (Coronary Heart Disease) 01/2009 - 12/2006
1	Alcoholic Fatty Liver 02/2022

Drug/Important Bio-Agent (IBA)

48	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 06/2002
40	Insulin (Novolin)FDA Link 01/2024 - 01/2002
29	FructoseIBA 01/2024 - 02/2002
26	AdiponectinIBA 01/2019 - 02/2002
24	LipidsIBA 01/2023 - 04/2003
23	LeptinIBA 10/2021 - 02/2002
20	Triglycerides (Triacylglycerol)IBA 01/2021 - 02/2002
13	SugarsIBA 01/2024 - 02/2004
10	Hormones (Hormone)IBA 01/2020 - 02/2002
7	Oxytocin (Pitocin)FDA LinkGeneric 10/2021 - 03/2015
7	Lipoproteins (Lipoprotein)IBA 10/2021 - 01/2009
6	GhrelinIBA 01/2016 - 04/2003
5	Sucrose (Saccharose)IBA 01/2024 - 06/2013
5	High Fructose Corn SyrupIBA 01/2024 - 06/2013
5	Glucagon (Glukagon)FDA Link 11/2021 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2008
4	Fish OilsIBA 01/2020 - 12/2010
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2016 - 04/2014
4	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2015 - 11/2004
3	Aspartame (NutraSweet)IBA 01/2024 - 01/2018
3	Liraglutide FDA Link 01/2023 - 10/2010
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2021 - 10/2010
3	Uric Acid (Urate)IBA 10/2021 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
3	Dietary SugarsIBA 01/2020 - 05/2009
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 02/2002
3	des-Arg-(77)- complement C3aIBA 12/2013 - 02/2002
3	salicylhydroxamic acid (SHAM)IBA 12/2013 - 06/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2022 - 02/2008
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022 - 01/2021
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 02/2008
2	C-PeptideIBA 12/2020 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 03/2006
2	NitrogenIBA 01/2017 - 01/2017
2	Protein Tyrosine PhosphatasesIBA 01/2017 - 04/2009
2	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2017
2	CarbohydratesIBA 01/2016 - 11/2008
2	Insulin ReceptorIBA 09/2014 - 06/2002
2	Bile Acids and Salts (Bile Acids)IBA 03/2013 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013 - 09/2002
2	Blood Glucose (Blood Sugar)IBA 10/2012 - 11/2007
2	EnzymesIBA 01/2012 - 08/2011
2	Leptin ReceptorsIBA 12/2010 - 10/2009
2	Tyrosine (L-Tyrosine)FDA Link 04/2009 - 06/2002
2	ApolipoproteinsIBA 11/2008 - 04/2003
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2024
1	pimonidazoleIBA 03/2024
1	Butyrates (Butyrate)IBA 03/2024
1	Oxygen (Dioxygen)IBA 03/2024
1	PlasticsIBA 12/2023
1	CollagenIBA 12/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023
1	Oxidants (Oxidizing Agents)IBA 05/2022
1	AntioxidantsIBA 05/2022
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Lys(8)- oxytocin (OXL)IBA 02/2022
1	OxylipinsIBA 02/2022
1	EndocannabinoidsIBA 02/2022

Therapy/Procedure

6	Bariatric Surgery 12/2023 - 06/2008
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 04/2003
3	Therapeutics 11/2021 - 11/2006
2	Intraperitoneal Injections 03/2024 - 01/2021
2	Glycemic Control 11/2021 - 02/2006
1	Euthanasia (Mercy Killing) 03/2024
1	Synchrotrons 12/2023